AlzeCure Pharma

AlzeCure Pharma is a Swedish pharmaceutical company engaged in innovative drug research with a primary focus on Alzheimers disease and pain. The company is listed on Nasdaq First North Premier Growth Market and is developing five drug candidates based on the two research platforms, NeuroRestore and Alzstatin. The NeuroRestore platform comprises symptom-relieving drug candidates while Alzstatin comprises disease modifying and preventive drug candidates. A diversified portfolio of drug candidates that act on central signaling pathways in the brain also opens up for other indications such as cognitive dysfunctions in traumatic brain injury (TBI), sleep apnea and Parkinsons disease. The company...

Drug discovery research,alzheimer's disease,neurodegenerative diseases,and pain management

Alzecure pharma operates in the Pharmaceutical manufacturing industry.

Alzecure pharma's revenue is 11m - 100m

Alzecure pharma has 11 - 50 employees.